Published in South Med J on April 01, 1984
Are Frozen Foods a Public Health Problem? Am J Public Health Nations Health (1947) 3.44
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med (2005) 3.13
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
No evidence for lipid peroxidation in severe preeclampsia. Am J Obstet Gynecol (2001) 2.28
Bactericidal effects of polyunsaturated fatty acids. J Infect Dis (1986) 1.96
Energy-dependent calcium sequestration activity in rat liver microsomes. J Biol Chem (1975) 1.91
Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. FASEB J (1998) 1.89
Ionophores stimulate prostaglandin and thromboxane biosynthesis. Proc Natl Acad Sci U S A (1977) 1.82
Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol (1993) 1.76
Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry (1993) 1.60
Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans. Clin Sci (Lond) (2001) 1.59
Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med (1994) 1.54
Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J (1991) 1.54
Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometry. Prostaglandins (1979) 1.48
Clinical implications of prostaglandin and thromboxane A2 formation (1). N Engl J Med (1988) 1.45
Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation (1999) 1.44
Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med (2005) 1.42
Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. J Pharmacol Exp Ther (1995) 1.38
14,15-Epoxyeicosatrienoic acid metabolism in endothelial cells. J Lipid Res (1993) 1.36
Biosynthesis of prostaglandin D2. 1. Formation of prostaglandin D2 by human platelets. Prostaglandins (1977) 1.36
In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N Engl J Med (1986) 1.36
Paracetemol poisoning--a brief report. Ir Med J (1977) 1.32
The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha. J Pharmacol Exp Ther (1997) 1.31
Clinical implications of prostaglandin and thromboxane A2 formation (2). N Engl J Med (1988) 1.19
Longitudinal follow-up comparison of educational interventions: multimedia textbook, traditional lecture, and printed textbook. Acad Radiol (1997) 1.16
Circadian rhythm of baroreflex reactivity and adrenergic vascular response. Cardiovasc Res (1980) 1.15
Sanitation and Quality Control in the Fishery Industries. Am J Public Health Nations Health (1937) 1.15
Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. Am J Respir Crit Care Med (1998) 1.12
Increased excretion of leukotriene E4 during aspirin-induced asthma. J Lab Clin Med (1992) 1.11
Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon. Br Med J (Clin Res Ed) (1986) 1.10
Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin. Am Rev Respir Dis (1990) 1.08
Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites. Mol Pharmacol (1993) 1.07
Endogenous biosynthesis of prostacyclin during cardiac catheterization and angiography in man. Circulation (1985) 1.05
Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator. Proc Natl Acad Sci U S A (1989) 1.04
Circulating adrenaline and blood pressure: the metabolic effects and kinetics of infused adrenaline in man. Eur J Clin Invest (1980) 1.04
Circadian variation in adrenergic responses in asthmatic subjects. Clin Sci (Lond) (1982) 1.00
Measurement of renal and non-renal eicosanoid synthesis. Am J Med (1986) 0.99
Suppression of eicosanoid biosynthesis during coronary angioplasty by fish oil and aspirin. Circulation (1991) 0.97
Calcium-dependent stimulation of thromboxane and prostaglandin biosynthesis by ionophores. Adv Prostaglandin Thromboxane Res (1978) 0.96
Allergen-stimulated release of mediators into sheep bronchoalveolar lavage fluid. Effect of cyclooxygenase inhibition. Am Rev Respir Dis (1989) 0.96
Arachidonic acid diols produced by cytochrome P-450 monooxygenases are incorporated into phospholipids of vascular endothelial cells. J Biol Chem (1996) 0.96
Long-lived enzymatic metabolites of thromboxane B2 in the human circulation. Anal Biochem (1986) 0.95
Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease. J Intern Med (2008) 0.94
Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation. J Pharmacol Exp Ther (1991) 0.93
Reduced brain metabolism in hyperactive girls. J Am Acad Child Adolesc Psychiatry (1994) 0.93
Endogenous prostacyclin synthesis is decreased during activation of the renin-angiotensin system in man. J Clin Endocrinol Metab (1984) 0.90
Stimulation of prostaglandin biosynthesis in the renal papilla by hypertonic mediums. Am J Physiol (1978) 0.90
Cellular activation by thromboxane A2 and other eicosanoids. Eur Heart J (1993) 0.89
Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs. Am J Physiol Lung Cell Mol Physiol (2000) 0.89
Biopharmaceutical characterisation of a low-dose (75 mg) controlled-release aspirin formulation. Br J Clin Pharmacol (1993) 0.89
A low temperature flotation method to rapidly isolate lipoproteins from plasma. J Lipid Res (1998) 0.89
Synthesis and metabolism of prostaglandins E2, F2alpha and D2 by the rat gastrointestinal tract. Stimulation by a hypertonic environment in vitro. Prostaglandins (1978) 0.88
Leukotriene B4 synthesis and neutrophil chemotaxis in chronic granulocytic leukaemia. J Clin Pathol (1988) 0.88
Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects. J Pharmacol Exp Ther (1982) 0.87
The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group. Pediatr Infect Dis J (1998) 0.86
Intravenous prostacyclin in thrombotic thrombocytopenic purpura. Ann Intern Med (1981) 0.84
The effect of sex on certain properties of the very low density lipoprotein secreted by the liver. Biochem Biophys Res Commun (1974) 0.83
The translational therapeutics of prostaglandin inhibition in atherothrombosis. J Thromb Haemost (2009) 0.83
Omega-3 fatty acids, endogenous prostaglandins, and blood pressure regulation in humans. Nutr Rev (1989) 0.82
Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation. Am Rev Respir Dis (1989) 0.81
Effects of dietary fat content, saturated fatty acids, and fish oil on eicosanoid production and hemostatic parameters in normal men. J Lab Clin Med (1994) 0.80
Eicosanoid biosynthesis in human cardiovascular disease. Hum Pathol (1987) 0.80
The effect of linoleic, arachidonic and eicosapentaenoic acid supplementation on prostacyclin production in rats. Lipids (1994) 0.80
Excretion of prostacyclin and thromboxane A2 metabolites during leg exercise in humans. Am J Physiol (1988) 0.80
Effects of feeding ethyl-dihomo-gamma-linolenate on rabbit renomedullary lipid composition and prostaglandin production in vitro. Lipids (1978) 0.79
Dietary fish oil accelerates the response to coronary thrombolysis with tissue-type plasminogen activator. Evidence for a modest platelet inhibitory effect in vivo. Circulation (1990) 0.79
Effects of intravenous dextroamphetamine on brain metabolism in adults with attention-deficit hyperactivity disorder (ADHD). Preliminary findings. Psychopharmacol Bull (1994) 0.79
Prostaglandins and calcium. Ann N Y Acad Sci (1978) 0.79
Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment. J Thromb Haemost (2003) 0.78
No evidence for antagonism of clonidine by naloxone in man [proceedings]. Br J Clin Pharmacol (1980) 0.78
Histocompatibility antigens and haemochromatosis in Ireland. Ir J Med Sci (1980) 0.78
Cyclooxygenase-dependent formation of the isoprostane 8-epi prostaglandin F2 alpha. Ann N Y Acad Sci (1994) 0.78
Monovalent cations and renomedullary prostaglandin release. Adv Prostaglandin Thromboxane Res (1980) 0.78
Aspirin reduces the prothrombotic activity of C-reactive protein. J Thromb Haemost (2009) 0.78
Pre and postsynaptic alpha-receptor agonists and the rate of release of noradrenaline in man [proceedings]. Br J Clin Pharmacol (1979) 0.78
Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649. Clin Pharmacol Ther (2012) 0.77
Cellular activation of thromboxane receptors. Ann N Y Acad Sci (1994) 0.77
A prostacyclin analog impairs the response to tissue-type plasminogen activator during coronary thrombolysis: evidence for a pharmacokinetic interaction. J Pharmacol Exp Ther (1991) 0.77
Molecular cloning of the human platelet 12-lipoxygenase. Trans Assoc Am Physicians (1990) 0.77
Hyperlipidemia and fatty acid composition in patients treated for type IA glycogen storage disease. J Pediatr (1991) 0.76
An effect of estradiol and testosterone on the calcium pump activity and phospholipid fatty acid composition of rat liver microsomes. Endocrinology (1977) 0.76
The effect of prostacyclin on pituitary hormone release. Br J Clin Pharmacol (1980) 0.76
Effects of feeding ethyl-dihomo-gamma-linolenate on prostaglandin biosynthesis and platelet aggregation in the rabbit. Biochim Biophys Acta (1976) 0.76
Cyclooxygenase dependent formation of 8-iso-prostaglandin F2 alpha by human platelets. Adv Prostaglandin Thromboxane Leukot Res (1995) 0.76
Cellular activation by thromboxane A2 and 8-EPI-PGF2 alpha. Adv Exp Med Biol (1997) 0.76
Vovulus of the small bowel in a diabetic patient. Br Med J (1976) 0.75
Drug-nutrient interactions in medical training. J Am Coll Nutr (1995) 0.75
Vascular effects of infused adenosine are not mediated by prostacyclin release in humans. Am J Physiol (1987) 0.75
Fatty acid-related functions. Am J Clin Nutr (1996) 0.75
Identification of arachidonate epoxides/diols by capillary chromatography-mass spectrometry. J Lipid Res (1995) 0.75
Digitoxin-quinidine interaction: potentiation during administration of cimetidine. South Med J (1981) 0.75
Beta-adrenoreceptor down-regulation by dynamic exercise and upright posture in man. Trans Assoc Am Physicians (1981) 0.75
Erythrocytes catechol-O-methyltransferase activity and indices of sympathetic activity in man. Clin Sci (Lond) (1980) 0.75
Essential fatty acid deficiency impairs the responsiveness of renal pelvic sensory receptors. Am J Physiol (1995) 0.75
Fish oils in cardiovascular disease. J Intern Med Suppl (1989) 0.75
Effects of oral administration of dihomo-gamma-linolenic acid on prostaglandin biosynthesis and platelet aggregation in the rabbit. Adv Prostaglandin Thromboxane Res (1976) 0.75
The kinetics and concentration-effect relationships of circulating adrenaline in man [proceedings]. Br J Clin Pharmacol (1980) 0.75
Consequences dietary ethanol on permeability and respiration of mitochondria and liver ADH in young and aged rats. Curr Alcohol (1979) 0.75
Health Problems in Packing Crustacean Products. Am J Public Health Nations Health (1939) 0.75